Literature DB >> 15964303

Urokinase-induced smooth muscle cell migration requires PI3-K and Akt activation.

Irfan I Galaria1, Suzanne M Nicholl, Elisa Roztocil, Mark G Davies.   

Abstract

OBJECTIVE: To examine the role of the phospho-inositol-3'-kinase (PI3-K)-akt signaling axis during smooth muscle cell (SMC) migration in response to the aminoterminal fragment of urokinase (ATF).
BACKGROUND: Urokinase (uPA) is involved in vessel remodeling and mediates smooth muscle cell migration. Migration in response to urokinase is dependent on ATF. The role of PI3-K/akt signaling during migration in response to the uPA fragments is not understood.
METHODS: Murine arterial SMCs were cultured in vitro. Linear wound and Boyden microchemotaxis assays of migration were performed in the presence of ATF with and without the PI3-K inhibitors (Wortmannin, Wn [10 nm] and LY294002, LY [10 microm]) and an akt inhibitor (aktI, [10 microm]). Western blotting was performed for akt, ERK1/2, and GSK3beta phosphorylation after cells were stimulated with ATF in the presence and absence of the inhibitors. Statistics were analyzed by one-way ANOVA.
RESULTS: Both PI3-K and akt inhibitors blocked the migratory response to ATF in both assays. ATF induced time-dependent increases in akt phosphorylation at both S472 and T308 sites and ERK1/2 phosphorylation. Activation of akt and ERK1/2 was inhibited by Wn and LY. Manumycin A, a ras inhibitor, did not inhibit activation of akt but did inhibit ERK1/2 activation. Activation of akt and the dephosphorylation of its downstream kinase GSK3beta were inhibited by the akt inhibitor. Direct inhibition of akt did not influence ERK1/2 activation and inhibition of ERK1/2 did not influence akt activation.
CONCLUSION: ATF mediated migration is PI3-K dependent and activates two separate pathways: ERK1/2 and akt. ATF induces akt phosphorylation through a PI3K-mediated but ras-independent mechanism while both ras and PI3K are required for ERK1/2 activation. Defining key signaling pathways is vital to regulate vessel remodeling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964303     DOI: 10.1016/j.jss.2005.02.022

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  11 in total

Review 1.  Migration of airway smooth muscle cells.

Authors:  William T Gerthoffer
Journal:  Proc Am Thorac Soc       Date:  2008-01-01

Review 2.  Motility, survival, and proliferation.

Authors:  William T Gerthoffer; Dedmer Schaafsma; Pawan Sharma; Saeid Ghavami; Andrew J Halayko
Journal:  Compr Physiol       Date:  2012-01       Impact factor: 9.090

3.  Mechanisms of kringle fragment of urokinase-induced vascular smooth muscle cell migration.

Authors:  Elisa Roztocil; Suzanne M Nicholl; Mark G Davies
Journal:  J Surg Res       Date:  2007-07       Impact factor: 2.192

4.  Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR2.

Authors:  Gretchen A Larusch; Alona Merkulova; Fakhri Mahdi; Zia Shariat-Madar; Robert G Sitrin; Douglas B Cines; Alvin H Schmaier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-24       Impact factor: 4.733

5.  Epidermal growth factor synergism with TGF-beta1 via PI-3 kinase activity in corneal keratocyte differentiation.

Authors:  Jiucheng He; Haydee E P Bazan
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07       Impact factor: 4.799

6.  Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism.

Authors:  Andrew M Bakken; Clinton D Protack; Elisa Roztocil; Suzanne M Nicholl; Mark G Davies
Journal:  J Vasc Surg       Date:  2009-05       Impact factor: 4.268

7.  Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with beta1 integrins.

Authors:  Chi-Hui Tang; Marla L Hill; Alexis N Brumwell; Harold A Chapman; Ying Wei
Journal:  J Cell Sci       Date:  2008-10-21       Impact factor: 5.285

8.  Urokinase expression by tumor suppressor protein p53: a novel role in mRNA turnover.

Authors:  Praveenkumar Shetty; Thirunavukkarasu Velusamy; Yashodhar P Bhandary; Rashmi S Shetty; Ming-Cheh Liu; Sreerama Shetty
Journal:  Am J Respir Cell Mol Biol       Date:  2008-04-03       Impact factor: 6.914

9.  Urokinase requires NAD(P)H oxidase to transactivate the epidermal growth factor receptor.

Authors:  Enrico A Duru; Yuyang Fu; Mark G Davies
Journal:  Surgery       Date:  2012-05-08       Impact factor: 3.982

10.  Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.

Authors:  Baoqing Tian; Xiaojia Chen; Huihua Zhang; Xiaoyan Li; Jiakang Wang; Wei Han; Li-Yi Zhang; Li Fu; Yan Li; Changjun Nie; Ying Zhao; Xuan Tan; Hailong Wang; Xin-Yuan Guan; An Hong
Journal:  Oncotarget       Date:  2017-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.